Daniel M Cushman1, Ryan Mattie2, Nathan D Clements3, Zachary L McCormick4. 1. Division of PM&R, University of Utah, Salt Lake City, UT(∗). 2. Department of Orthopaedic Surgery, PM&R, Stanford University, Redwood City, CA; Stanford University Health Care, Stanford Outpatient Medical Center, 450 Broadway St, Pavilion C, MC 6342, Redwood City, CA 94063(†). Electronic address: rmattie@standford.edu. 3. University of Utah School of Medicine, Salt Lake City, UT(‡). 4. Department of PM&R/Department of Anesthesiology, Northwestern University, Chicago, IL(§).
Abstract
BACKGROUND: Intra-articular hip injections are commonly performed for both diagnostic and therapeutic interventions. Because of the risk of damage to neurovascular structures, fluoroscopic guidance with injection of contrast material has been established as the gold standard to ensure proper needle placement into the intra-articular space. However, fluoroscopically guided intra-articular hip injections put patients at risk due to radiation exposure. OBJECTIVE: To examine the relationship between body mass index (BMI) and fluoroscopy time and radiation dose during intra-articular hip injections. DESIGN: Retrospective study. SETTING: The study was conducted at an academic orthopedic center. All procedures were performed by physicians board-certified in PM&R and/or with subspecialty certification in sports medicine, or by a trainee under close supervision from an attending physician. PARTICIPANTS: All patients who underwent fluoroscopically guided intra-articular hip injections between the years 2003-2014 with a documented height/weight, fluoroscopy time, and radiation dose. INTERVENTIONS: All patients received unilateral or bilateral intra-articular hip injections with fluoroscopic guidance. Fluoroscopy time and dose were recorded. MAIN OUTCOME MEASURES: The main outcome measures were fluoroscopy time and radiation dose. A Bonferroni correction was implemented for multiple comparisons, defining statistical significance at P < .01. RESULTS: A total of 438 subjects (446 injections) were included. Mean fluoroscopy times were 17.4 ± 9.9, 17.5 ± 11.4, and 19.1 ± 13.4 seconds for normal, overweight, and obese body mass (BMI) index groups, respectively, with no significant difference between groups (P = .148). The mean radiation doses were 601 ± 690, 678 ± 558, and 1049 ± 812 mGy-cm(2), respectively (P < .001, r = 0.29). There was no association of age (P = .03), needle length (P = .34) or trainee involvement (P = .159) with fluoroscopy time. CONCLUSION: This study demonstrates that increasing BMI leads to elevated radiation dose during fluoroscopically guided intra-articular hip injections. The increased radiation experienced by patients with a larger BMI, however, is likely negligible.
BACKGROUND:Intra-articular hip injections are commonly performed for both diagnostic and therapeutic interventions. Because of the risk of damage to neurovascular structures, fluoroscopic guidance with injection of contrast material has been established as the gold standard to ensure proper needle placement into the intra-articular space. However, fluoroscopically guided intra-articular hip injections put patients at risk due to radiation exposure. OBJECTIVE: To examine the relationship between body mass index (BMI) and fluoroscopy time and radiation dose during intra-articular hip injections. DESIGN: Retrospective study. SETTING: The study was conducted at an academic orthopedic center. All procedures were performed by physicians board-certified in PM&R and/or with subspecialty certification in sports medicine, or by a trainee under close supervision from an attending physician. PARTICIPANTS: All patients who underwent fluoroscopically guided intra-articular hip injections between the years 2003-2014 with a documented height/weight, fluoroscopy time, and radiation dose. INTERVENTIONS: All patients received unilateral or bilateral intra-articular hip injections with fluoroscopic guidance. Fluoroscopy time and dose were recorded. MAIN OUTCOME MEASURES: The main outcome measures were fluoroscopy time and radiation dose. A Bonferroni correction was implemented for multiple comparisons, defining statistical significance at P < .01. RESULTS: A total of 438 subjects (446 injections) were included. Mean fluoroscopy times were 17.4 ± 9.9, 17.5 ± 11.4, and 19.1 ± 13.4 seconds for normal, overweight, and obese body mass (BMI) index groups, respectively, with no significant difference between groups (P = .148). The mean radiation doses were 601 ± 690, 678 ± 558, and 1049 ± 812 mGy-cm(2), respectively (P < .001, r = 0.29). There was no association of age (P = .03), needle length (P = .34) or trainee involvement (P = .159) with fluoroscopy time. CONCLUSION: This study demonstrates that increasing BMI leads to elevated radiation dose during fluoroscopically guided intra-articular hip injections. The increased radiation experienced by patients with a larger BMI, however, is likely negligible.
Authors: Heather Roesly; Michael Archibeck; A Michael Henrie; Justin Provo; Justin Foley; Andrew Boyer; Masaru Teramoto; Daniel M Cushman Journal: J Orthop Date: 2022-09-14
Authors: James D Wylie; Michael P McClincy; Evan K Stieler; Michael B Millis; Young-Jo Kim; Christopher L Peters; Eduardo N Novais Journal: J Hip Preserv Surg Date: 2019-09-17